Human MAIT cells inhibit alloreactive T-cell responses and protect from acute graft-versus-host disease
N Talvard-Balland, M Lambert, MF Chevalier… - JCI …, 2024 - Am Soc Clin Investig
Adoptive transfer of immune regulatory cells can prevent or ameliorate graft-versus-host
disease (GVHD), which remains the main cause of non-relapse mortality after allogeneic …
disease (GVHD), which remains the main cause of non-relapse mortality after allogeneic …
[HTML][HTML] ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
…, N Núñez, J Norona, N Talvard-Balland… - Nature …, 2024 - nature.com
Patients with corticosteroid-refractory acute graft-versus-host disease (aGVHD) have a low
one-year survival rate. Identification and validation of novel targetable kinases in patients …
one-year survival rate. Identification and validation of novel targetable kinases in patients …
[HTML][HTML] Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy
M Tourret, N Talvard-Balland, M Lambert… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Mucosal-associated invariant T (MAIT) cells are semi-invariant T cells that
recognize microbial antigens presented by the highly conserved MR1 molecule. MAIT cells are …
recognize microbial antigens presented by the highly conserved MR1 molecule. MAIT cells are …
[PDF][PDF] Expansion of Circulating CD49b+ LAG3+ Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease
N Talvard-Balland, AS Del Galy, D Michonneau… - Journal of Investigative …, 2021 - Elsevier
Chronic graft-versus-host disease (cGVHD) remains the main cause of morbidity and 62
mortality after allogeneic hematopoietic stem cell transplantation (AHSCT). cGVHD is a 63 …
mortality after allogeneic hematopoietic stem cell transplantation (AHSCT). cGVHD is a 63 …
Dr. Nana Talvard-Balland
N Talvard-Balland - J Immunother, 2021 - cibss.uni-freiburg.de
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is the primary curative treatment
for patients with acute myeloid leukemia (AML). The therapeutic benefit of allo-HCT relies …
for patients with acute myeloid leukemia (AML). The therapeutic benefit of allo-HCT relies …
Fonction régulatrice des lymphocytes MAIT dans un modèle expérimental de réaction du greffon contre l'hôte (GvHD)
N Talvard-Balland - 2020 - theses.fr
L’allogreffe de cellules souches hématopoïétiques est indiquée dans le traitement de
nombreuses hémopathies malignes. Le bénéfice curatif de cette thérapie repose sur la capacité …
nombreuses hémopathies malignes. Le bénéfice curatif de cette thérapie repose sur la capacité …
Etude de l'effet des lignes de traitement sur l'activité des CAR T dans le Myélome Multiple
A Abecassis - 2021 - theses.hal.science
… A Nana Talvard-Balland, Ma Nana Bella pour tous ces moments de bonheur partagés.
Je te souhaite une magnifique carrière dans la recherche. …
Je te souhaite une magnifique carrière dans la recherche. …
[CITATION][C] LACK OF ALLOREACTIVE POTENTIAL OF HUMAN MUCOSA ASSOCIATED INVARIANT T CELLS
N Talvard-Balland, M Tourret… - …, 2019 - … ST, HOBOKEN 07030-5774, NJ USA